Therapies based on messenger RNA, such as mRNA vaccines, have revolutionary potential. mRNA therapeutics offer precise and individualized therapy and avoid manufacturing issues associated with recombinant proteins. Compared with current therapeutics, mRNA production is more cost-effective, faster, and more flexible.
Interested in mRNA vaccines or therapeutics? Discover how we can support production and manufacturing.